128 related articles for article (PubMed ID: 25550854)
1. Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients.
Wang ZS; Cong ZJ; Luo Y; Mu YF; Qin SL; Zhong M; Chen JJ
Int J Clin Exp Pathol; 2014; 7(11):8077-81. PubMed ID: 25550854
[TBL] [Abstract][Full Text] [Related]
2. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
[TBL] [Abstract][Full Text] [Related]
4. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-36α suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis.
Xie X; Hu H; He J; Liu Y; Guo F; Luo F; Jiang M; Wang L
FEBS Open Bio; 2021 May; 11(5):1353-1363. PubMed ID: 33713575
[TBL] [Abstract][Full Text] [Related]
8. IL-36α suppresses proliferation of ovarian cancer cells.
Chang L; Guo R; Yuan Z
Tumour Biol; 2017 Jun; 39(6):1010428317706918. PubMed ID: 28621240
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung YC; Chaen YL; Hsu CP
Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
[TBL] [Abstract][Full Text] [Related]
10. The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium.
Frey S; Derer A; Messbacher ME; Baeten DL; Bugatti S; Montecucco C; Schett G; Hueber AJ
Ann Rheum Dis; 2013 Sep; 72(9):1569-74. PubMed ID: 23268368
[TBL] [Abstract][Full Text] [Related]
11. The combination of nuclear factor kappa B, cyclo-oxygenase-2 and vascular endothelial growth factor expression predicts poor prognosis in stage II and III colorectal cancer.
Kim NK; Park JK; Shin E; Kim YW
Anticancer Res; 2014 Nov; 34(11):6451-7. PubMed ID: 25368245
[TBL] [Abstract][Full Text] [Related]
12. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
[TBL] [Abstract][Full Text] [Related]
13. TUFM is a potential new prognostic indicator for colorectal carcinoma.
Shi H; Hayes M; Kirana C; Miller R; Keating J; Macartney-Coxson D; Stubbs R
Pathology; 2012 Oct; 44(6):506-12. PubMed ID: 22772342
[TBL] [Abstract][Full Text] [Related]
14. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
15. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
16. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
17. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
Deng YJ; Tang N; Liu C; Zhang JY; An SL; Peng YL; Ma LL; Li GQ; Jiang Q; Hu CT; Wang YN; Liang YZ; Bian XW; Fang WG; Ding YQ
Clin Cancer Res; 2014 Jul; 20(14):3809-17. PubMed ID: 24916695
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SIRT1 is a poor prognostic factor for advanced colorectal cancer.
Jiang K; Lyu L; Shen Z; Zhang J; Zhang H; Dong J; Yan Y; Liu F; Wang S
Chin Med J (Engl); 2014; 127(11):2021-4. PubMed ID: 24890145
[TBL] [Abstract][Full Text] [Related]
19. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
